RepliCel Life Sciences, Inc.: DermaPrecise Injection System Shown to Produce Consistently High Cell Count and Viability for Cell Therapy Injections
Independent Testing Performed by Innovacell Demonstrates the DermaPrecise Control Leads to Unparalleled Post-Injection Cell Survival and Viability ConsistencyVANCOUVER, BC / ACCESSWIRE / August 2, 2022
Source: finanznachrichten.de